The average one-year price target for Liontown (ASX:LTR) has been revised to $1.15 / share. This is an increase of 22.39% from the prior estimate of $0.94 dated December 3, 2025. The price target is ...

The average one-year price target for Liontown Resources (ASX:LTR) has been revised to $0.87 / share. This is an increase of 17.47% from the prior estimate of $0.74 dated November 7, 2025. The price ...

Key Insights Significant control over Liontown by retail investors implies that the general public has more power ...

Significant control over LTR Pharma by private companies implies that the general public has more power to influence management and governance-related decisions 51% of the business is held by the top ...

We think all investors should try to buy and hold high quality multi-year winners. While not every stock performs well, when investors win, they can win big. To wit, the Liontown Resources Limited ...

Pilbara Minerals and others have reset their 52-week highs as lithium commodity prices continue to rise. The post 12 ASX ...

Liontown Resources (ASX: LTR) shares are down 32%. LTR shares are down on the withdrawal of Albemarle’s (NYSE: ALB) bid for the company. Plus the large rights issue that has now been launched to bring ...

The LTR Pharma EPS (TTM) is -0.03. LTR Pharma reported sales of The LTR Pharma EPS (TTM) is -0.03. LTR Pharma reported sales of 1.06, net income of -3.19, and EPS of -0.02 for the latest quarter., net ...

ASX company news and announcements for LTR Pharma Ltd (LTP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All LTR Pharma Ltd (LTP) ASX ...